Posts by: Sreetama Dutt

Sreetama Dutt

Sreetama Dutt is a news curator and info page creator for the website. She studied biotechnology at SRM Institute of Science and Technology, and did her Masters in medical microbiology at University of Manchester in Manchester, UK.

September 11, 2015October 28, 2015

Zafgen Completes Phase 2 Clinical Trial Enrollment For Obesity Therapy Beloranib

News

Zafgen, a biotechnology company developing treatments for obesity and complex metabolic disorders, recently announced the completion of patient recruitment for ZAF-203, a Phase 2b clinical trial for beloranib, a therapy ... Read more

May 21, 2015May 21, 2015

Maternal Obesity Poses Serious Threat To The Neonate’s Immune System At Birth

News

Obesity remains a major public health concern in the United States, where most of the complications due to obesity (including heart attacks, strokes, diabetes, cancer and hypertension) are eventually fatal. ... Read more

Posts by: Sreetama Dutt

Sreetama Dutt

Zafgen Completes Phase 2 Clinical Trial Enrollment For Obesity Therapy Beloranib

Maternal Obesity Poses Serious Threat To The Neonate’s Immune System At Birth

Related Posts

Pin It on Pinterest